Decision Support in Medicine: Uveitis
1. Does this patient have uveitis?
Uveitis is defined as inflammation of the uveal tract including the iris, ciliary body, and choroid. Uveitis is classified by anatomical location which... (Source: Rheumatology News)
Source: Rheumatology News - March 16, 2016 Category: Rheumatology Source Type: research
Spending on physicians rising faster than health expenditures overall
Spending on physicians rose by 2.4% per year from 2003 to 2013 – the largest increase among the major components of national health expenditures, according to the Agency for Healthcare Research and... (Source: Rheumatology News)
Source: Rheumatology News - March 15, 2016 Category: Rheumatology Source Type: research
Sparse, poor evidence supports fumarates for psoriasis
Even though fumaric acid esters are increasingly considered to be a suitable, even a first-line, systemic treatment for moderate to severe psoriasis in some parts of Europe, the evidence supporting... (Source: Rheumatology News)
Source: Rheumatology News - March 15, 2016 Category: Rheumatology Source Type: research
New CDC opioid guideline targets overprescribing for chronic pain
Nonopioid therapy is the preferred approach for managing chronic pain outside of active cancer, palliative, and end-of-life care, according to a new guideline released today by the Centers for... (Source: Rheumatology News)
Source: Rheumatology News - March 15, 2016 Category: Rheumatology Source Type: research
Anti-Remicade antibodies also cross-react with infliximab biosimilar
Antibodies to the innovator infliximab drug Remicade found in rheumatoid arthritis and spondyloarthritis patients also cross-react with the infliximab biosimilar CT-P13, marketed as Remsima or... (Source: Rheumatology News)
Source: Rheumatology News - March 14, 2016 Category: Rheumatology Source Type: research
Fresh evidence of methotrexate efficacy in psoriatic arthritis
MAUI, HAWAII – The effectiveness of methotrexate in psoriatic arthritis is a matter of debate, but Dr. Arthur Kavanaugh is a believer based in part upon a recent subanalysis of the TICOPA study.... (Source: Rheumatology News)
Source: Rheumatology News - March 13, 2016 Category: Rheumatology Source Type: research
Expert examines secukinumab’s role in ankylosing spondylitis treatment strategies
MAUI, HAWAII – The most important development within the past year in the treatment of ankylosing spondylitis was the Food and Drug Administration approval of secukinumab (Cosentyx) as the first... (Source: Rheumatology News)
Source: Rheumatology News - March 12, 2016 Category: Rheumatology Source Type: research
VIDEO: How to navigate value-based care payer contracts
AUSTIN, TEX. – The shift from volume- to value-based care has become a regular hot topic among the medical community. But one rarely discussed question is how quality-based care will impact physician... (Source: Rheumatology News)
Source: Rheumatology News - March 11, 2016 Category: Rheumatology Source Type: research
Don’t overlook topical tazarotene for psoriasis
WAIKOLOA, HAWAII – Tazarotene remains an important and effective albeit greatly underutilized topical therapy in psoriasis – but it’s on its way to becoming an even better drug, Dr. Linda Stein Gold... (Source: Rheumatology News)
Source: Rheumatology News - March 10, 2016 Category: Rheumatology Source Type: research
60 weeks of ixekizumab effective, well tolerated in moderate-to-severe plaque psoriasis
WASHINGTON – After 60 weeks of continuous therapy with the investigational drug ixekizumab, 722 patients who initially had moderate to severe plaque psoriasis had Psoriasis Area Severity Index (PASI)... (Source: Rheumatology News)
Source: Rheumatology News - March 10, 2016 Category: Rheumatology Source Type: research
Registry study adds evidence for use of DMARD combo first in early RA
A treat-to-target protocol involving methotrexate plus hydroxychloroquine, along with an optional intramuscular triamcinolone acetonide injection, led to remission more quickly in patients with early... (Source: Rheumatology News)
Source: Rheumatology News - March 10, 2016 Category: Rheumatology Source Type: research
Minimal disease activity criteria in PsA falls short
The minimal disease activity criteria used to identify low disease activity in psoriatic arthritis (PsA) may not be useful as a treatment target in patients with extended skin involvement, according... (Source: Rheumatology News)
Source: Rheumatology News - March 9, 2016 Category: Rheumatology Source Type: research
Forgoing artificial nutrition and hydration
Question: Which of the following statements regarding artificial nutrition and hydration (ANH) is least supported in ethics and/or law?
A. One may invoke medical futility and... (Source: Rheumatology News)
Source: Rheumatology News - March 9, 2016 Category: Rheumatology Source Type: research
Low incidence, mortality described for mixed connective tissue disease
Mixed connective tissue disease (MCTD) occurred with an annual incidence of 1.9 cases per 100,000 individuals in a population-based study of adults conducted during 1985-2014 in Olmsted County,... (Source: Rheumatology News)
Source: Rheumatology News - March 8, 2016 Category: Rheumatology Source Type: research
Brodalumab met primary endpoints, deaths called ‘unrelated’
The investigational interleukin-17 inhibitor brodalumab met both primary endpoints in a phase III, double-blind, placebo-controlled trial of 661 patients with moderate to severe plaque psoriasis,... (Source: Rheumatology News)
Source: Rheumatology News - March 7, 2016 Category: Rheumatology Source Type: research
